![Thomas Jarrett MD](https://res.cloudinary.com/els-assets/image/upload/c_fill_pad,f_auto,g_auto,h_150,q_auto,w_120/v1/practice-update/remote-media/contentimage/691.jpg)
Thomas W. Jarrett MD
Professor and Chairman, Department of Urology, The George Washington University School of Medicine & Health Sciences, Washington, DCThomas Jarrett, MD, is board-certified in Urology. He is a professor and Chairman of Urology at The George Washington University School of Medicine & Health Sciences. He graduated magna cum laude from Duke University and went on to receive his medical degree from Emory University. He completed his residency at The New York Hospital – Cornell Medical Center and fellowship in endouruology at Island Jewish Medical Center. Dr. Jarrett has a primary of interest in minimally invasive approaches to upper urinary tract malignancies.
Recent Contributions to PracticeUpdate:
- Antegrade Administration of Mitomycin Gel Via a Percutaneous Nephrostomy Tube in Patients With UTUC
- Durability of Response to Primary Chemoablation of Low-Grade UTUC Using UGN-101
- Pretreatment Risk Stratification for Endoscopic Kidney-Sparing Surgery in Upper Tract Urothelial Carcinoma
- Endoscopic Treatment for Upper Tract Urothelial Carcinoma
- Nephroureterectomy vs Segmental Ureterectomy of Clinically Localized, High-Grade, Urothelial Carcinoma of the Ureter
- Adjuvant Chemotherapy in Upper Tract Urothelial Carcinoma
- Percutaneous Core Needle Biopsy for Upper Tract Urothelial Carcinoma
- Segmental Resection of Distal Ureter With Termino-Terminal Ureteric Anastomosis vs Bladder Cuff Removal and Ureteric Re-Implantation for Upper Tract Urothelial Carcinoma
- Optimal Sequence of Chemotherapy for Upper Tract Urothelial Carcinoma With Clinically Positive Regional Lymph Nodes
- MicroRNA Expression Profiles in Upper Tract Urothelial Carcinoma Differentiate Tumor Grade, Stage, and Survival